Morgan Stanley Veru Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Veru Inc. stock. As of the latest transaction made, Morgan Stanley holds 246,161 shares of VERU stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

246,161

Previous 376,367 34.6%

Holding current value

$1.09 Million

Previous $184,000 22.83%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$0.49 - $0.7 $63,800 - $91,144	-130,206 Reduced 34.6%	246,161 $142,000
Q1 2025 May 15, 2025	SELL	$0.45 - $1.28 $489,479 - $1.39 Million	-1,087,732 Reduced 74.29%	376,367 $184,000
Q4 2024 Feb 14, 2025	SELL	$0.58 - $0.93 $899,309 - $1.44 Million	-1,550,534 Reduced 51.43%	1,464,099 $951,000
Q3 2024 May 14, 2025	BUY	$0.77 - $1.04 $170,176 - $229,849	221,009 Added 7.91%	3,014,633 $2.32 Million
Q3 2024 Nov 14, 2024	BUY	$0.77 - $1.04 $170,176 - $229,849	221,009 Added 7.91%	3,014,633 $2.32 Million
Q2 2024 May 14, 2025	BUY	$0.76 - $1.79 $1.01 Million - $2.38 Million	1,329,525 Added 90.81%	2,793,624 $2.35 Million
Q2 2024 Oct 17, 2024	BUY	$0.76 - $1.79 $46,987 - $110,666	61,825 Added 2.26%	2,793,624 $2.35 Million
Q2 2024 Aug 14, 2024	BUY	$0.76 - $1.79 $46,987 - $110,666	61,825 Added 2.26%	2,793,624 $2.35 Million
Q1 2024 Oct 17, 2024	SELL	$0.37 - $0.72 $22,875 - $44,514	-61,825 Reduced 2.21%	2,731,799 $1.91 Million
Q1 2024 Aug 16, 2024	BUY	$0.37 - $0.72 $621 - $1,209	1,680 Added 0.06%	2,731,799 $1.91 Million
Q1 2024 May 15, 2024	BUY	$0.37 - $0.72 $621 - $1,209	1,680 Added 0.06%	2,731,799 $1.91 Million
Q4 2023 Aug 16, 2024	SELL	$0.67 - $1.17 $42,548 - $74,300	-63,505 Reduced 2.27%	2,730,119 $1.97 Million
Q4 2023 Feb 13, 2024	SELL	$0.67 - $1.17 $723,145 - $1.26 Million	-1,079,321 Reduced 28.33%	2,730,119 $1.97 Million
Q3 2023 Nov 15, 2023	SELL	$0.72 - $1.33 $981,223 - $1.81 Million	-1,362,810 Reduced 26.35%	3,809,440 $2.74 Million
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.49 $1.92 Million - $2.93 Million	-1,964,262 Reduced 27.52%	5,172,250 $6.15 Million
Q1 2023 May 15, 2023	SELL	$1.16 - $6.41 $182,444 - $1.01 Million	-157,280 Reduced 2.16%	7,136,512 $8.28 Million
Q4 2022 Feb 14, 2023	BUY	$4.78 - $15.01 $4.54 Million - $14.3 Million	949,478 Added 14.97%	7,293,792 $38.5 Million
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $54.6 Million - $127 Million	5,340,137 Added 531.79%	6,344,314 $73.1 Million
Q2 2022 Oct 27, 2022	BUY	$4.35 - $15.85 $3.56 Million - $13 Million	818,261 Added 440.12%	1,004,177 $11.3 Million
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $3.56 Million - $13 Million	818,261 Added 440.12%	1,004,177 $11.3 Million
Q1 2022 Oct 27, 2022	SELL	$4.55 - $6.41 $3.72 Million - $5.25 Million	-818,261 Reduced 81.49%	185,916 $898,000
Q1 2022 May 13, 2022	SELL	$4.55 - $6.41 $575,834 - $811,230	-126,557 Reduced 40.5%	185,916 $898,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $195,324 - $322,666	-33,162 Reduced 9.59%	312,473 $1.84 Million
Q3 2021 Nov 15, 2021	BUY	$6.78 - $9.89 $2.34 Million - $3.42 Million	345,635 New	345,635 $2.95 Million

Others Institutions Holding VERU

# of Institutions

129

Shares Held

43.5M

Call Options Held

50.5K

Put Options Held

824K

View Full List

About VERU INC.

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $355M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

More about VERU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account